155 related articles for article (PubMed ID: 38343861)
1. Enhancing Chemotherapy Response Prediction via Matched Colorectal Tumor-Organoid Gene Expression Analysis and Network-Based Biomarker Selection.
Zhang W; Wu C; Huang H; Bleu P; Zambare W; Alvarez J; Wang L; Paty PB; Romesser PB; Smith JJ; Chen XS
medRxiv; 2024 May; ():. PubMed ID: 38343861
[TBL] [Abstract][Full Text] [Related]
2. Identification of Hub Genes Associated With Sensitivity of 5-Fluorouracil Based Chemotherapy for Colorectal Cancer by Integrated Bioinformatics Analysis.
Wang Y; Wei Q; Chen Y; Long S; Yao Y; Fu K
Front Oncol; 2021; 11():604315. PubMed ID: 33912443
[TBL] [Abstract][Full Text] [Related]
3. Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study.
Nomiri S; Hoshyar R; Chamani E; Rezaei Z; Salmani F; Larki P; Tavakoli T; Gholipour F; Tabrizi NJ; Derakhshani A; Santarpia M; Franchina T; Brunetti O; Silvestris N; Safarpour H
Biomed Pharmacother; 2022 Mar; 147():112691. PubMed ID: 35151227
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer.
He XS; Zou SY; Yao JL; Yu W; Deng ZY; Wang JR; Gan WJ; Wan S; Yang XQ; Wu H
Front Mol Biosci; 2021; 8():763652. PubMed ID: 34722636
[No Abstract] [Full Text] [Related]
5. Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
Chen L; Tian B; Liu W; Liang H; You Y; Liu W
Front Oncol; 2022; 12():855674. PubMed ID: 35425715
[TBL] [Abstract][Full Text] [Related]
6. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Prediction Based on Weighted Gene Co-Expression Network Analysis and Variational Auto-Encoder.
Ai D; Wang Y; Li X; Pan H
Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32825264
[TBL] [Abstract][Full Text] [Related]
9. An epithelial-mesenchymal transition-related prognostic model for colorectal cancer based on weighted gene co-expression network analysis.
Zhang L; Qian Y
J Int Med Res; 2022 Dec; 50(12):3000605221140683. PubMed ID: 36510452
[TBL] [Abstract][Full Text] [Related]
10. Screening prognostic genes related to leucovorin, fluorouracil, and irinotecan treatment sensitivity by performing co-expression network analysis for colon cancer.
Wu P; Pan X; Lu K; Gu N
Front Genet; 2022; 13():928356. PubMed ID: 36523769
[No Abstract] [Full Text] [Related]
11. Weighted gene co-expression network analysis combined with machine learning validation to identify key hub biomarkers in colorectal cancer.
Guo C; Xie B; Liu Q
Funct Integr Genomics; 2022 Dec; 23(1):24. PubMed ID: 36576616
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.
Mo X; Su Z; Yang B; Zeng Z; Lei S; Qiao H
Oncol Lett; 2020 Jan; 19(1):177-186. PubMed ID: 31897128
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes in colorectal cancer diagnosis by co-expression analysis weighted gene co-expression network analysis.
Mortezapour M; Tapak L; Bahreini F; Najafi R; Afshar S
Comput Biol Med; 2023 May; 157():106779. PubMed ID: 36931200
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
15. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
17. Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer.
Wei FZ; Mei SW; Wang ZJ; Chen JN; Shen HY; Zhao FQ; Li J; Liu Z; Liu Q
Front Oncol; 2020; 10():573295. PubMed ID: 33251137
[TBL] [Abstract][Full Text] [Related]
18. Weighted gene co-expression network analysis identified MYL9 and CNN1 are associated with recurrence in colorectal cancer.
Qiu X; Cheng SH; Xu F; Yin JW; Wang LY; Zhang XY
J Cancer; 2020; 11(8):2348-2359. PubMed ID: 32127961
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
